{"disease":{"id":"childhood-brain-tumor","name":"childhood brain tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03586401","title":"Creating a Decision Support System for the Corporate Management of Physical Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","has_results":false},{"nct_id":"NCT07381959","title":"Biomarkers of Brain Injury in Children With Brain Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":560,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT02914067","title":"Cognitive Biomarkers in Pediatric Brain Tumor Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05857969","title":"Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":65,"lead_sponsor_name":"Florida International University","has_results":false},{"nct_id":"NCT04798859","title":"The Child in Context Intervention Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Sunnaas Rehabilitation Hospital","has_results":false},{"nct_id":"NCT03936465","title":"Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05202925","title":"Musical Training Programme to Improve Neurocognitive Functioning of Children Surviving Brain Tumours","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"The Hong Kong Polytechnic University","has_results":false},{"nct_id":"NCT06770335","title":"The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Great Ormond Street Hospital for Children NHS Foundation Trust","has_results":false},{"nct_id":"NCT02255461","title":"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Pediatric Brain Tumor Consortium","has_results":true},{"nct_id":"NCT03860376","title":"Ex Vivo Drug Sensitivity Testing and Mutation Profiling","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Florida International University","has_results":false},{"nct_id":"NCT00638898","title":"Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03911388","title":"HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06104488","title":"A Study of Avutometinib for People With Solid Tumor Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":23,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT07457255","title":"Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Institute of Oncology Ljubljana","has_results":false},{"nct_id":"NCT06193759","title":"Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Children's National Research Institute","has_results":false},{"nct_id":"NCT02444546","title":"Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}